KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Biogen (BIIB) Leases (2016 - 2025)

Biogen has reported Leases over the past 17 years, most recently at $265.4 million for Q4 2025.

  • Quarterly results put Leases at $265.4 million for Q4 2025, down 25.53% from a year ago — trailing twelve months through Dec 2025 was $265.4 million (down 25.53% YoY), and the annual figure for FY2025 was $265.4 million, down 25.53%.
  • Leases for Q4 2025 was $265.4 million at Biogen, down from $330.5 million in the prior quarter.
  • Over the last five years, Leases for BIIB hit a ceiling of $460.9 million in Q3 2023 and a floor of $265.4 million in Q4 2025.
  • Median Leases over the past 5 years was $384.8 million (2021), compared with a mean of $378.4 million.
  • Biggest five-year swings in Leases: rose 14.14% in 2023 and later dropped 25.53% in 2025.
  • Biogen's Leases stood at $375.4 million in 2021, then grew by 7.59% to $403.9 million in 2022, then rose by 3.99% to $420.0 million in 2023, then decreased by 15.14% to $356.4 million in 2024, then dropped by 25.53% to $265.4 million in 2025.
  • The last three reported values for Leases were $265.4 million (Q4 2025), $330.5 million (Q3 2025), and $334.5 million (Q2 2025) per Business Quant data.